APA (7th ed.) Citation

A, V., BS, T., AHK, N., JN, H., ON, K., M, K. N., . . . Y, S. (2023). Prevalence of geographic atrophy in Nordic countries and number of patients potentially eligible for intravitreal complement inhibitor treatment: A systematic review with meta-analyses and forecasting study. Acta ophthalmologica, 101(8), 857. https://doi.org/10.1111/aos.15768

Chicago Style (17th ed.) Citation

A, Vangsted, Thinggaard BS, Nissen AHK, Hajari JN, Klefter ON, Krogh Nielsen M, Sørensen TL, Grauslund J, and Subhi Y. "Prevalence of Geographic Atrophy in Nordic Countries and Number of Patients Potentially Eligible for Intravitreal Complement Inhibitor Treatment: A Systematic Review with Meta-analyses and Forecasting Study." Acta Ophthalmologica 101, no. 8 (2023): 857. https://doi.org/10.1111/aos.15768.

MLA (9th ed.) Citation

A, Vangsted, et al. "Prevalence of Geographic Atrophy in Nordic Countries and Number of Patients Potentially Eligible for Intravitreal Complement Inhibitor Treatment: A Systematic Review with Meta-analyses and Forecasting Study." Acta Ophthalmologica, vol. 101, no. 8, 2023, p. 857, https://doi.org/10.1111/aos.15768.